InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,480.68
(
0.29%
)
US TECH 100
19,114.40
(
-0.48%
)
Dow Jones
39,495.36
(
0.88%
)
Brent Oil
85.18
(
1.38%
)
Bitcoin
60,893.59
(
-3.59%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DanWebzster

Send PM Follow Ignore
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

DanWebzster

Member Level

Re: DanWebzster post# 144

Monday, 05/07/2018 8:41:20 AM

Monday, May 07, 2018 8:41:20 AM

Post# of 438
INSP had rev growth of 74% in 2017

Recent IPO targets sleep apnea market.

markets a medical device that monitors breathing patterns and delivers nerve stimulation to maintain open airways. The device consists of a remote control and 3 implantable components including a sensing lead, stimulator and stimulation lead.

1/3 of those with CPAP machines are noncompliant. 70% of those are eligible for the INSP solution.

5/17 Company is richly valued at 14x sales.

Public company RMD is competition and potential acquirer.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up